Zimmer Biomet Stock Falls As Weakness In Latin America And Certain EU Markets Impact Organic Growth Forecast

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported third-quarter adjusted earnings of $1.90 per share, up 9.2% year over year, beating the Street estimates of $1.87.The orthopedic implant maker reported sales of $2.001 billion, up 7% on a reported basis, up 5.4% on a constant currency basis, and 2.8% on an organic constant currency basis, almost in line with the consensus of $2.005 billion.Knee product sales increased 6.3% to $792.4 million (+5.3% organically), and hip product sales increased 5.1% (+3.8%) to ...